Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
1d
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...
Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...
Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback